OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
5
Results
Show all
Save search
Copy query
Show results for
Unknown
(5)
Publication Date
Release Date
2022
(2)
2024
(1)
2023
(1)
2018
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial.
Not available
S-EPMC5829656
|
biostudies-literature
Cite
Efficacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: A systematic review and meta-analysis of 42 randomized controlled trials.
Not available
S-EPMC9701736
|
biostudies-literature
Cite
The antidepressant effect of Shexiang Baoxin Pills on myocardial infarction rats with depression may be achieved through the inhibition of the NLRP3 inflammasome pathway.
Not available
S-EPMC11226411
|
biostudies-literature
Cite
Efficacy of Chinese traditional patent medicines for heart failure with preserved ejection fraction: a Bayesian network meta-analysis of 64 randomized controlled trials.
Not available
S-EPMC10694238
|
biostudies-literature
Cite
The comparative effects of oral Chinese patent medicines combined with western medicine in stable angina: A systematic review and network meta-analysis of 179 trials.
Not available
S-EPMC9428755
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets